To assess global changes in the amounts of GPI-anchored proteins in ALS, we measured the amount of GPI-anchored proteins in patient CSF using tandem-mass-tag (TMT) mass spectrometry (MS), which provides sensitive quantitative measurement of CSF proteins (Fig. 4A). This evidence concerns the gene GPI and amyotrophic lateral sclerosis.